With COVID-19, people with diabetes face the added risk of poorer outcomes if infected, creating an even greater urgency to ensure proper management of overall health and chronic conditions.

As a nation we've reached a tipping point as to what patients can bear when it comes to the price of insulin, a drug used to control blood sugar levels for people with insulin-dependent diabetes. Millions of people who need this life-saving medication face affordability barriers in the form of rising insulin prices and out-of-pocket costs.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.